Usiak MF - Search Results

1

Genetic differences affecting the potency of stereoisomers of isoflurane.

Morgan PG, Usiak MF, Sedensky MM. Morgan PG, et al. Among authors: usiak mf. Anesthesiology. 1996 Aug;85(2):385-92. doi: 10.1097/00000542-199608000-00021. Anesthesiology. 1996. PMID: 8712455

2

Neuromuscular activity blockade induced by muscimol and d-tubocurarine differentially affects the survival of embryonic chick motoneurons.

Usiak MF, Landmesser LT. Usiak MF, et al. J Neurosci. 1999 Sep 15;19(18):7925-39. doi: 10.1523/JNEUROSCI.19-18-07925.1999. J Neurosci. 1999. PMID: 10479694 Free PMC article.

3

Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid.

Tabaton M, Nunzi MG, Xue R, Usiak M, Autilio-Gambetti L, Gambetti P. Tabaton M, et al. Biochem Biophys Res Commun. 1994 May 16;200(3):1598-603. doi: 10.1006/bbrc.1994.1634. Biochem Biophys Res Commun. 1994. PMID: 8185615

4

Alzheimer's disease and control brain contain soluble derivatives of the amyloid protein precursor that end within the beta amyloid protein region.

Pasternack JM, Palmert MR, Usiak M, Wang R, Zurcher-Neely H, Gonzalez-De Whitt PA, Fairbanks MB, Cheung T, Blades D, Heinrikson RL, et al. Pasternack JM, et al. Biochemistry. 1992 Nov 10;31(44):10936-40. doi: 10.1021/bi00159a038. Biochemistry. 1992. PMID: 1420205

5

Expression of beta amyloid protein precursor mRNAs: recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR.

Golde TE, Estus S, Usiak M, Younkin LH, Younkin SG. Golde TE, et al. Neuron. 1990 Feb;4(2):253-67. doi: 10.1016/0896-6273(90)90100-t. Neuron. 1990. PMID: 2106330

6

Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor.

Estus S, Golde TE, Kunishita T, Blades D, Lowery D, Eisen M, Usiak M, Qu XM, Tabira T, Greenberg BD, et al. Estus S, et al. Science. 1992 Feb 7;255(5045):726-8. doi: 10.1126/science.1738846. Science. 1992. PMID: 1738846

7

Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease.

Palmert MR, Usiak M, Mayeux R, Raskind M, Tourtellotte WW, Younkin SG. Palmert MR, et al. Neurology. 1990 Jul;40(7):1028-34. doi: 10.1212/wnl.40.7.1028. Neurology. 1990. PMID: 2113204

8

Soluble derivatives of the beta amyloid protein precursor of Alzheimer's disease are labeled by antisera to the beta amyloid protein.

Palmert MR, Siedlak SL, Podlisny MB, Greenberg B, Shelton ER, Chan HW, Usiak M, Selkoe DJ, Perry G, Younkin SG. Palmert MR, et al. Biochem Biophys Res Commun. 1989 Nov 30;165(1):182-8. doi: 10.1016/0006-291x(89)91052-8. Biochem Biophys Res Commun. 1989. PMID: 2480122

9

Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease.

Palmert MR, Golde TE, Cohen ML, Kovacs DM, Tanzi RE, Gusella JF, Usiak MF, Younkin LH, Younkin SG. Palmert MR, et al. Among authors: usiak mf. Science. 1988 Aug 26;241(4869):1080-4. doi: 10.1126/science.2457949. Science. 1988. PMID: 2457949

10

In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer disease.

Cohen ML, Golde TE, Usiak MF, Younkin LH, Younkin SG. Cohen ML, et al. Among authors: usiak mf. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1227-31. doi: 10.1073/pnas.85.4.1227. Proc Natl Acad Sci U S A. 1988. PMID: 3277188 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters